Signal Transduction and Targeted Therapy · 2023 · 61 citations · 30 references
Life SciencesBiologyInfectious DiseasesMolecular VirologyStructural BiologyVirologyAntiviral ImmunityAntiviral TherapyProtein StructureProtein TargetingViral PathologyViral Protein ProcessingBroad-spectrum Antiviral AgentsE3 Ubiquitin Ligase Substrate RecognitionProteasome SystemTargeted Protein DegradationUbiquitin-mediated ProteolysisUbiquitin-proteasome ProteolysisViral Entry InhibitorsViral Protein Degradation
The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a severe global health crisis; its structural protein envelope (E) is critical for viral entry, budding, production, and induction of pathology which makes it a potential target for therapeutics against COVID-19. Here, we find that the E3 ligase RNF5 interacts with and catalyzes ubiquitination of E on the 63rd lysine, leading to its degradation by the ubiquitin-proteasome system (UPS). Importantly, RNF5-induced degradation of E inhibits SARS-CoV-2 replication and the RNF5 pharmacological activator Analog-1 alleviates disease development in a mouse infection model. We also found that RNF5 is distinctively expressed in different age groups and in patients displaying different disease severity, which may be exploited as a prognostic marker for COVID-19. Furthermore, RNF5 recognized the E protein from various SARS-CoV-2 strains and SARS-CoV, suggesting that targeting RNF5 is a broad-spectrum antiviral strategy. Our findings provide novel insights into the role of UPS in antagonizing SARS-CoV-2 replication, which opens new avenues for therapeutic intervention to combat the COVID-19 pandemic.
30
TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines
Min Zheng, Rajendra Karki, Evan P. Williams et al. · Nature Immunology · 2021 · 617 citations · Full text
José L. Nieto-Torres, Marta L. DeDiego, Carmina Verdiá-Báguena et al. · PLoS Pathogens · 2014 · 583 citations · Full text
Ubiquitination independent of E1 and E2 enzymes by bacterial effectors
Jiazhang Qiu, Michael J. Sheedlo, Kaiwen Yu et al. · Nature · 2016 · 376 citations